MedTrace Logo

Comparing Follow-Up Schedules in Patients With Newly Diagnosed Stage IB or Stage II Melanoma

NCT01018004 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 178

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Gathering information over time from follow-up visits may help doctors plan the best follow-up schedule. It is not yet known which follow-up schedule is more effective in improving patient quality of life.

PURPOSE: This randomized clinical trial is comparing follow-up schedules to see how well they work in patients with newly diagnosed stage IB or stage II melanoma.

Conditions

  • Melanoma (Skin)

Interventions

OTHER

follow-up care

OTHER

questionnaire administration

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • University Medical Center Groningen

    lead OTHER

Principal Investigators

  • Harald J. Hoekstra, MD, PhD · University Medical Center Groningen

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2011-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01018004 on ClinicalTrials.gov